Literature DB >> 8978514

Airway reactivity in welders: a controlled prospective cohort study.

W S Beckett1, P E Pace, S J Sferlazza, G D Perlman, A H Chen, X P Xu.   

Abstract

In a 3-year survey, respiratory symptoms, spirometry, and methacholine reactivity were measured annually in welders (n = 51) and non-welder controls subjects (n = 54) to determine whether welding-related symptoms are associated with accelerated decline in lung function or changes in airway reactivity. In the cross-workshift study, maximal midexpiratory flow rate declined reversibly during a welding day, whereas 1-second forced expiratory volume and forced-vital capacity were unchanged. In the longitudinal study, the welders had significantly more reversible work-related symptoms of cough, phlegm, wheeze, and chest tightness than the non-welder shipyard control subjects. In this group of actively working welders, across-workshift changes in midflow and reversible symptoms were related to the welding occupation, but evidence for chronic irreversible effects on spirometry or airway reactivity was not seen over the 3 years of observation. The short period of observation was not optimal for detecting a chronic effect on lung function. Work practices and engineering controls may be successfully preventing irreversible respiratory effects, but not mild reversible effects, in this group of welders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8978514     DOI: 10.1097/00043764-199612000-00008

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  11 in total

1.  Two year follow up of pulmonary function values among welders in New Zealand.

Authors:  R Erkinjuntti-Pekkanen; T Slater; S Cheng; D Fishwick; L Bradshaw; M Kimbell-Dunn; L Dronfield; N Pearce
Journal:  Occup Environ Med       Date:  1999-05       Impact factor: 4.402

2.  Acute decrease in HDL cholesterol associated with exposure to welding fumes.

Authors:  Mary Berlik Rice; Jenn Cavallari; Shona Fang; David Christiani
Journal:  J Occup Environ Med       Date:  2011-01       Impact factor: 2.162

3.  Intracellular zinc irritates TRPA1.

Authors:  Tue G Banke; Alan D Wickenden
Journal:  Nat Chem Biol       Date:  2009-03       Impact factor: 15.040

4.  Dust is in the air. Part II: Effects of occupational exposure to welding fumes on lung function in a 9-year study.

Authors:  Daniela Haluza; Hanns Moshammer; Karl Hochgatterer
Journal:  Lung       Date:  2013-11-12       Impact factor: 2.584

5.  Lung health among plumbers and pipefitters in Edmonton, Alberta.

Authors:  P A Hessel; L S Melenka; D Michaelchuk; F A Herbert; R L Cowie
Journal:  Occup Environ Med       Date:  1998-10       Impact factor: 4.402

6.  Exposure to welding fumes is associated with acute systemic inflammatory responses.

Authors:  J Y Kim; J-C Chen; P D Boyce; D C Christiani
Journal:  Occup Environ Med       Date:  2005-03       Impact factor: 4.402

7.  A welder with pneumosiderosis: a case report.

Authors:  Imran Khalid; Tabindeh J Khalid; Jeffrey H Jennings
Journal:  Cases J       Date:  2009-04-20

8.  Synergistic impaired effect between smoking and manganese dust exposure on pulmonary ventilation function in Guangxi manganese-exposed workers healthy cohort (GXMEWHC).

Authors:  Fenfen Wang; Yunfeng Zou; Yuefei Shen; Yaoqiu Zhong; Yingnan Lv; Damin Huang; Kangcheng Chen; Qin Li; Li Qing; Bing Xia; Cheng Su; Shuyan Ma; Xiaobo Yang
Journal:  PLoS One       Date:  2015-02-09       Impact factor: 3.240

9.  Respiratory function and bronchial responsiveness among industrial workers exposed to different classes of occupational agents: a study from Algeria.

Authors:  Farid Ould-Kadi; Tim S Nawrot; Peter H Hoet; Benoit Nemery
Journal:  J Occup Med Toxicol       Date:  2007-10-08       Impact factor: 2.646

10.  A prospective study of decline in lung function in relation to welding emissions.

Authors:  Sigve W Christensen; Jens Peter Bonde; Oyvind Omland
Journal:  J Occup Med Toxicol       Date:  2008-02-26       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.